Eugene Williams
First SEC filing: July 7, 2022 · Latest: July 7, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN | A | 11,000 | · | · | 11,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 20, 2026 | PMN | A | 5,500 | · | · | 5,500 Direct | · | Acquired | (price as of 2026-10-05) |
| March 5, 2026 | PMN | P | 2,000 | $24.40 | $48,800 | 12,397 Direct | +19.24% | Acquired | -61.6% (price as of 2026-10-05) |
| March 4, 2026 | PMN | P | 2,000 | $24.00 | $48,000 | 10,397 Direct | +23.82% | Acquired | -61.0% (price as of 2026-10-05) |
| March 3, 2026 | PMN | P | 1,000 | $21.89 | $21,890 | 8,397 Direct | +13.52% | Acquired | -57.2% (price as of 2026-10-05) |
| March 2, 2026 | PMN | P | 1,000 | $22.53 | $22,530 | 7,397 Direct | +15.63% | Acquired | -58.4% (price as of 2026-10-05) |
| June 12, 2025 | PMN | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 3, 2024 | PMN | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 16, 2022 | PMN | P | 1,000 | $4.65 | $4,650 | 158,930 Direct | +0.63% | Acquired | -91.9% (price as of 2026-10-05) |
| Dec. 16, 2022 | PMN | P | 1,000 | $4.64 | $4,640 | 159,930 Direct | +0.63% | Acquired | -91.9% (price as of 2026-10-05) |
| Dec. 12, 2022 | PMN | P | 1,000 | $5.08 | $5,080 | 157,930 Direct | +0.64% | Acquired | -92.6% (price as of 2026-10-05) |
| Dec. 7, 2022 | PMN | P | 1,000 | $5.49 | $5,490 | 156,930 Direct | +0.64% | Acquired | -93.2% (price as of 2026-10-05) |
| Dec. 2, 2022 | PMN | P | 1,000 | $5.98 | $5,980 | 155,930 Direct | +0.65% | Acquired | -93.7% (price as of 2026-10-05) |
| July 11, 2022 | PMN | P | 1,000 | $9.80 | $9,800 | 154,930 Direct | +0.65% | Acquired | -96.2% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN | Option (right to buy) | Common Shares | $10.77 | May 20, 2036 | 11,000 | Acquired |
| May 20, 2026 | PMN | Option (right to buy) | Common Shares | $10.77 | May 20, 2036 | 5,500 | Acquired |
| June 12, 2025 | PMN | Option (right to buy) | Common Shares | $0.50 | June 12, 2035 | 20,000 | Acquired |
| Oct. 3, 2024 | PMN | Option (right to buy) | Common Shares | $1.11 | Oct. 3, 2034 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 10 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 7, 2022 | PMN | Common Shares | 153,930 | Direct |
| July 7, 2022 | PMN | Option (right to buy) | 78,822 | Direct |
| July 7, 2022 | PMN | Option (right to buy) | 36,988 | Direct |
| July 7, 2022 | PMN | Option (right to buy) | 16,667 | Direct |
| July 7, 2022 | PMN | Option (right to buy) | 50,000 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy) | 833 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy) | 556 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy) | 1,927 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy) | 1,111 | Direct |
| July 7, 2022 | PMN | Warrants (right to buy) | 3,472 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $360,000 | · | · | · | · | · | $21,057 | $381,057 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.